A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet

• Principais autores: Hope Cottrill MD (Autor), Stephanie Cason (Autor), Scott Caroen (Autor), Bryan Oronsky MD (Autor), Elvis Donaldson MD (Autor)
• Formato: Livro
• Publicado em: SAGE Publishing, 2018-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

This case report describes the clinical course of a heavily pretreated patient enrolled on the Phase II QUADRUPLE THREAT clinical trial (NCT02489903) with recurrent metastatic epithelial ovarian cancer that was previously treated with a platinum doublet and that benefited from another reintroduction...